Charles Schwab Investment Management Inc Celcuity Inc. Transaction History

Charles Schwab Investment Management Inc

$521 Billion
Q1 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Celcuity Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 232,036 shares of CELC stock, worth $3.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

232,036

Previous 237,706 2.39%

Holding current value

$3.23 Million

Previous $3.11 Million 24.62%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$8.62 - $13.62 $48,875 - $77,225	-5,670 Reduced 2.39%	232,036 $2.35 Million
Q4 2024 Feb 06, 2025	BUY	$12.0 - $16.35 $192,420 - $262,172	16,035 Added 7.23%	237,706 $3.11 Million
Q3 2024 Nov 12, 2024	BUY	$13.98 - $19.15 $2.15 Million - $2.94 Million	153,712 Added 226.18%	221,671 $3.31 Million
Q2 2024 Aug 12, 2024	BUY	$14.1 - $20.78 $319,308 - $470,583	22,646 Added 49.98%	67,959 $1.11 Million
Q1 2024 May 08, 2024	BUY	$13.74 - $21.6 $494 - $777	36 Added 0.08%	45,313 $978,000
Q4 2023 Feb 06, 2024	SELL	$8.7 - $15.02 $16,303 - $28,147	-1,874 Reduced 3.97%	45,277 $659,000
Q3 2023 Nov 08, 2023	BUY	$8.96 - $10.75 $25,329 - $30,390	2,827 Added 6.38%	47,151 $430,000
Q2 2023 Aug 09, 2023	BUY	$9.39 - $12.18 $416,202 - $539,866	44,324 New	44,324 $486,000
Q2 2022 Aug 15, 2022	SELL	$5.35 - $10.11 $145,926 - $275,760	-27,276 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$7.93 - $13.33 $15,772 - $26,513	1,989 Added 7.87%	27,276 $256,000
Q3 2021 Nov 16, 2021	BUY	$17.35 - $24.87 $102,052 - $146,285	5,882 Added 30.31%	25,287 $456,000
Q2 2021 Aug 16, 2021	BUY	$14.25 - $30.93 $276,521 - $600,196	19,405 New	19,405 $466,000
Q2 2020 Aug 14, 2020	SELL	$4.42 - $11.04 $65,013 - $162,387	-14,709 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$19.88 - $25.0 $26,022 - $32,725	1,309 Added 9.77%	14,709 $368,000
Q3 2018 Nov 13, 2018	BUY	$20.96 - $30.77 $52,400 - $76,925	2,500 Added 22.94%	13,400 $386,000
Q2 2018 Aug 08, 2018	BUY	$16.13 - $26.99 $175,817 - $294,191	10,900 New	10,900 $271,000

Others Institutions Holding CELC

# of Institutions

Shares Held

30.6M

Call Options Held

16.2K

Put Options Held

51.9K

View Full List

About Celcuity Inc.

Ticker CELC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,941,300
Market Cap $208M
Description
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...

More about CELC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Celcuity Inc. Transaction History